Evidence map›Paper›PMID 27071959›Full record

ArticleContrast media & molecular imaging2016

Developing imidazoles as CEST MRI pH sensors.

Xing Yang, Xiaolei Song, Sangeeta Ray Banerjee, Yuguo Li, Youngjoo Byun, Guanshu Liu, Zaver M Bhujwalla, Martin G Pomper, Michael T McMahon

Abstract read
In one paragraph

Article in Contrast media & molecular imaging, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 39 papers.

0numbers the graph read from it
0cells of the map it votes in
39citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

39 citing papers in PubMed.

  1. Dynamic glucose-enhanced MRI in brain tumors.Magma (New York, N.Y.) · 2026
    Review
  2. Review
  3. Article
  4. Review
  5. Article
  6. Review
  7. Article
  8. Review
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Mapping kidney tubule diameter ex vivo by diffusion MRI.American journal of physiology. Renal physiology · 2021
    Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Xing YangRussell H. Morgan Department of Radiology, The Johns Hopkins University School of Medicine, Baltimore, MD, USA.
Xiaolei SongRussell H. Morgan Department of Radiology, The Johns Hopkins University School of Medicine, Baltimore, MD, USA.
Sangeeta Ray BanerjeeRussell H. Morgan Department of Radiology, The Johns Hopkins University School of Medicine, Baltimore, MD, USA.
Yuguo LiRussell H. Morgan Department of Radiology, The Johns Hopkins University School of Medicine, Baltimore, MD, USA.
Youngjoo ByunCollege of Pharmacy, Korea University, Sejong, South Korea.
Guanshu LiuRussell H. Morgan Department of Radiology, The Johns Hopkins University School of Medicine, Baltimore, MD, USA.
Zaver M BhujwallaRussell H. Morgan Department of Radiology, The Johns Hopkins University School of Medicine, Baltimore, MD, USA.
Martin G PomperRussell H. Morgan Department of Radiology, The Johns Hopkins University School of Medicine, Baltimore, MD, USA.
Michael T McMahonRussell H. Morgan Department of Radiology, The Johns Hopkins University School of Medicine, Baltimore, MD, USA.

Funding

Translational Research Central ServicesP30CA006973 · NCI · JOHNS HOPKINS UNIVERSITY · PI Rosalie Wollett · 1985 to 2026
$208.6M
PSMA-based Cancer Imaging AgentsR01CA134675 · NCI · UT SOUTHWESTERN MEDICAL CENTER · PI POMPER, MARTIN G · 2009 to 2025
$6.2M
Small Molecule PSMA-Targeted Alpha TherapyR01CA184228 · NCI · UT SOUTHWESTERN MEDICAL CENTER · PI POMPER, MARTIN G, ZALUTSKY, MICHAEL ROD · 2014 to 2023
$3.6M
Multi-Color Exchange Transfer Imaging of Drug Delivery NanocarriersR01EB015031 · NIBIB · HUGO W. MOSER RES INST KENNEDY KRIEGER · PI MCMAHON, MICHAEL T · 2011 to 2014
$2.4M
16.4T Vertical Wide Bore Animal MR ImagerS10RR025118 · NCRR · HUGO W. MOSER RES INST KENNEDY KRIEGER · PI MCMAHON, MICHAEL T · 2009 to 2009
$2.0M
PSMA-based MR Imaging and Therapy of Prostate CancerK25CA148901 · NCI · JOHNS HOPKINS UNIVERSITY · PI RAY, SANGEETA · 2011 to 2015
$580k
In vivo Molecular MR Imaging of Inflammation using NSAIDs as CEST agentsR21EB020905 · NIBIB · HUGO W. MOSER RES INST KENNEDY KRIEGER · PI SONG, XIAOLEI · 2016 to 2017
$444k
Specific Molecular Imaging Agents for Clear Cell Renal Cell Carcinoma DiagnosisR03CA197470 · NCI · JOHNS HOPKINS UNIVERSITY · PI YANG, XING · 2015 to 2016
$162k
NCI NIH HHS K25 CA148901NCI NIH HHS P30 CA006973NCI NIH HHS R01 CA134675NCI NIH HHS R01 CA184228NCI NIH HHS R03 CA197470NCRR NIH HHS S10 RR025118NIBIB NIH HHS R01 EB015031NIBIB NIH HHS R21 EB020905
6 · The paper itself

Abstract

A series of intra-molecular hydrogen bonded imidazoles and related heterocyclic compounds were screened for their N-H chemical exchange saturation transfer (CEST) magnetic resonance imaging (MRI) contrast properties. Of the compounds, imidazole-4,5-dicarboxamides (I45DCs) were found to provide the strongest contrast, with the contrast produced at a large chemical shift from water (7.8 ppm) and strongly dependent on pH. We have tested several probes based on this scaffold, and demonstrated that these probes could be applied for in vivo detection of kidney pH after intravenous administration. Copyright © 2016 John Wiley & Sons, Ltd.

Indexed as

AnimalsBiosensing TechniquesContrast MediaHydrogen-Ion ConcentrationImidazolesKidneyMagnetic Resonance ImagingMiceContrast MediaImidazoleschemical exchange saturation transferimidazole-4,5-dicarboxamidesmolecular imagingpH imaging

Identifiers

PMID27071959
PMCPMC5201433

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.